Aethlon Medical (AEMD) Tops Q3 EPS by 6c

Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.12), $0.06 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• Raymond James cuts Cigna to Outperform on lack of near-term catalysts
• Benchmark Reiterates Buy Rating on Sony Corp. (6785:JP) (SONY)